TMO in the 13F filings
Thermo Fisher Scientific Inc · CUSIP 883556102
- Quarter end
- 30 Sep 2026
- the date the book describes
- Filed
- 9 Nov 2026
- latest of these filings; the earliest 20 Oct 2026
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 5
- filed both Q2 2026 and Q3 2026; 3 listed it in both
- Shares listed
- 938,086
- combined, among listed positions
- Reported value
- $633m
- combined, at the quarter end
Among the 5 comparable managers: 3 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +49,204.
Managers listing TMO in Q3 2026
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Baillie Gifford & Co | 605,185 | $409m | 0.39% | Trimmed | -40,463 | 9 Nov 2026 (the filing on sec.gov) |
| Egerton Capital UK LLP | 198,227 | $134m | 1.36% | New | new | 20 Oct 2026 (the filing on sec.gov) |
| Markel Group Inc | 74,100 | $50m | 0.39% | Added | +1,000 | 30 Oct 2026 (the filing on sec.gov) |
| Squarepoint Ops LLC | 40,213 | $27m | under 0.1% | Trimmed | -126,816 | 9 Nov 2026 (the filing on sec.gov) |
| Acadian Asset Management LLC | 20,361 | $14m | under 0.1% | Added | +17,256 | 9 Nov 2026 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Egerton Capital UK LLPnew position · 198,227 shares now+198,227
- Acadian Asset Management LLCexisting position · 20,361 shares now+17,256
- Markel Group Incexisting position · 74,100 shares now+1,000
Reductions
- Squarepoint Ops LLCexisting position · 40,213 shares now-126,816
- Baillie Gifford & Coexisting position · 605,185 shares now-40,463
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 19 | $8.8bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.1bn | n.a. | n.a. |
| Q4 2013 | 19 | $12.6bn | n.a. | n.a. |
| Q1 2014 | 22 | $12.8bn | n.a. | n.a. |
| Q2 2014 | 22 | $12.9bn | n.a. | n.a. |
| Q3 2014 | 22 | $13.6bn | n.a. | n.a. |
| Q4 2014 | 30 | $14.7bn | n.a. | n.a. |
| Q1 2015 | 27 | $15.0bn | n.a. | n.a. |
| Q2 2015 | 27 | $14.1bn | n.a. | n.a. |
| Q3 2015 | 20 | $13.5bn | n.a. | n.a. |
| Q4 2015 | 21 | $15.4bn | n.a. | n.a. |
| Q1 2016 | 21 | $14.7bn | n.a. | n.a. |
| Q2 2016 | 20 | $14.9bn | n.a. | n.a. |
| Q3 2016 | 18 | $15.7bn | n.a. | n.a. |
| Q4 2016 | 31 | $13.2bn | n.a. | n.a. |
| Q1 2017 | 27 | $13.8bn | n.a. | n.a. |
| Q2 2017 | 29 | $15.7bn | n.a. | n.a. |
| Q3 2017 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2017 | 20 | $18.2bn | n.a. | n.a. |
| Q1 2018 | 28 | $20.1bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.9bn | n.a. | n.a. |
| Q3 2018 | 27 | $23.6bn | n.a. | n.a. |
| Q4 2018 | 30 | $21.6bn | n.a. | n.a. |
| Q1 2019 | 30 | $27.4bn | n.a. | n.a. |
| Q2 2019 | 33 | $28.8bn | n.a. | n.a. |
| Q3 2019 | 26 | $27.9bn | n.a. | n.a. |
| Q4 2019 | 26 | $30.3bn | n.a. | n.a. |
| Q1 2020 | 27 | $25.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $32.6bn | n.a. | n.a. |
| Q3 2020 | 29 | $38.9bn | n.a. | n.a. |
| Q4 2020 | 33 | $39.2bn | n.a. | n.a. |
| Q1 2021 | 35 | $36.5bn | n.a. | n.a. |
| Q2 2021 | 33 | $38.3bn | n.a. | n.a. |
| Q3 2021 | 32 | $42.6bn | n.a. | n.a. |
| Q4 2021 | 38 | $50.1bn | n.a. | n.a. |
| Q1 2022 | 32 | $43.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $38.9bn | n.a. | n.a. |
| Q3 2022 | 26 | $34.3bn | n.a. | n.a. |
| Q4 2022 | 29 | $37.0bn | n.a. | n.a. |
| Q1 2023 | 35 | $37.1bn | n.a. | n.a. |
| Q2 2023 | 39 | $33.5bn | n.a. | n.a. |
| Q3 2023 | 39 | $32.6bn | n.a. | n.a. |
| Q4 2023 | 41 | $32.7bn | 19 | 23 |
| Q1 2024 | 30 | $34.1bn | 14 | 18 |
| Q2 2024 | 38 | $30.6bn | 25 | 18 |
| Q3 2024 | 30 | $33.8bn | 12 | 19 |
| Q4 2024 | 36 | $27.6bn | 22 | 15 |
| Q1 2025 | 31 | $24.2bn | 12 | 22 |
| Q2 2025 | 39 | $18.8bn | 27 | 11 |
| Q3 2025 | 32 | $21.9bn | 22 | 13 |
| Q4 2025 | 32 | $29.9bn | 27 | 20 |
| Q1 2026 | 34 | $24.4bn | 23 | 23 |
| Q2 2026 | 36 | $26.4bn | 27 | 22 |
| Q3 2026 | 3 | $592m | 3 | 2 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMO and LLY →TMO and JNJ →TMO and VRTX →Choose a stock to compare with TMO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMO, latest filings →Back to the 13F Explorer →